TWO · —

Orient Pharma Co., Ltd. (4166.TWO) Stock

$23.80 -1.65% TWO: 4166.TWO —

—

Valuation

MetricValue
Price$23.80
Market Cap$5.95B
P/E Ratio25.00
P/B Ratio2.24
P/S Ratio3.93
EPS (TTM)$0.98
52-Week High$29.60
52-Week Low$22.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE10.42%
ROA6.29%
ROCE—
Gross Margin56.22%
Operating Margin18.26%
Net Margin15.52%
Debt/Equity0.07
Current Ratio7.39

Latest News

1 Financials Stock to Own for Decades and 2 We Avoid StockStory · Sep 10, 2026 TTW Names Top 50 Shopping Destinations in the World for 2026 PR Newswire · Sep 10, 2026 3 Profitable Stocks We Keep Off Our Radar StockStory · Sep 10, 2026 Citigroup (C) Completed a Weekend Tokenized-Dollar Transfer. Can the Network Scale? Insider Monkey · Sep 10, 2026 Anthropic Thwarted Misue of its AI Models, Including for Biological Weapons MT Newswires · Sep 10, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio0.13
EV / EBITDA14.09
FCF Yield—
Quick Ratio5.06
Interest Coverage—
Return 1Y-11.85%
Return 3Y26.60%
Return 5Y38.78%

Ownership

Insiders Held76.53%
Institutions Held0.00%
Institutions Float Held0.00%

About Orient Pharma Co., Ltd.

—

Orient Pharma Co., Ltd. (4166.TWO) stock trades at $23.80 with a market capitalization of $5.95B. The stock is valued at a price-to-earnings (P/E) ratio of 25.00, price-to-book of 2.24, price-to-sales of 3.93. Over the past 52 weeks the stock has ranged between $22.40 and $29.60, and currently trades 19.6% below its 52-week high.

On profitability, Orient Pharma Co., Ltd. generates a return on equity (ROE) of 10.42%, an operating margin of 18.26%, a net profit margin of 15.52%.

Official website: www.oppharma.com

Orient Pharma Co., Ltd. (4166.TWO) — frequently asked questions

What is Orient Pharma Co., Ltd. (4166.TWO) stock price today?

Orient Pharma Co., Ltd. (4166.TWO) is currently trading at $23.80, down 1.65% today.

What is 4166.TWO P/E ratio?

Orient Pharma Co., Ltd.'s P/E ratio is 25.00. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is 4166.TWO return on equity (ROE)?

Orient Pharma Co., Ltd.'s return on equity (ROE) is 10.42%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Orient Pharma Co., Ltd.'s market cap?

Orient Pharma Co., Ltd. has a market capitalization of $5.95B.

Does 4166.TWO pay a dividend?

Orient Pharma Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does 4166.TWO carry?

Orient Pharma Co., Ltd. has a debt-to-equity ratio of 0.07. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 4166.TWO's profit margin?

Orient Pharma Co., Ltd. reports a net profit margin of 15.52% — the share of revenue left after every cost, including tax and interest.

What sector is 4166.TWO in?

Orient Pharma Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 4166.TWO listed on?

Orient Pharma Co., Ltd. trades on TWO under the ticker 4166.TWO.

What is 4166.TWO's 52-week range?

Over the last year Orient Pharma Co., Ltd. has traded between $22.40 and $29.60.

Related — Stocks

BSP Bending Spoons S.p.A. $46.63 +2.15% PS Pershing Square Inc. $45.55 +1.65% MAIR Madison Air Solutions Corporation $22.92 +0.70% QNT Quantinuum Inc. $37.53 +7.44% USDE StablecoinX Inc. $1.00 -0.01% BVC BitVentures Limited $14.00 +13.91% PURR Hyperliquid Strategies Inc. $9.07 +1.11% HBNB Hotel101 Global Holdings Corp. $4.42 -8.45% BLSM BlossomHill Therapeutics, Inc. $16.39 +15.75% FCBM First Carolina Financial Services, Inc. $12.93 +3.44% BRBI BRBI BR Partners S.A. $9.85 -30.68% QMLS QumulusAI, Inc. $3.14 -16.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 4166.TWO currently matches

On the figures above, Orient Pharma Co., Ltd. passes the filters for 8 of our ready-made screens, among them Low Debt Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksStocks Under $100Stocks Under $50High Gross Margin StocksMid Cap StocksStocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.